Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,806 | 893 | 57.1% |
| Consulting Fee | $8,870 | 6 | 28.4% |
| Honoraria | $2,750 | 2 | 8.8% |
| Long term medical supply or device loan | $1,365 | 15 | 4.4% |
| Education | $409.69 | 15 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,756 | 132 | $0 (2024) |
| SECURA BIO, INC. | $4,187 | 12 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $3,040 | 46 | $0 (2024) |
| GENZYME CORPORATION | $1,731 | 21 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $1,479 | 85 | $0 (2023) |
| Genentech USA, Inc. | $1,400 | 70 | $0 (2024) |
| Epizyme, Inc., | $1,366 | 8 | $0 (2022) |
| Kite Pharma, Inc. | $1,154 | 2 | $0 (2021) |
| Janssen Biotech, Inc. | $844.44 | 33 | $0 (2024) |
| PFIZER INC. | $837.93 | 58 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,574 | 69 | Janssen Biotech, Inc. ($147.08) |
| 2023 | $2,458 | 92 | Novartis Pharmaceuticals Corporation ($248.97) |
| 2022 | $3,630 | 109 | GENZYME CORPORATION ($1,372) |
| 2021 | $5,951 | 114 | Secura Bio, Inc. ($2,331) |
| 2020 | $4,928 | 68 | Novartis Pharmaceuticals Corporation ($1,492) |
| 2019 | $4,834 | 151 | Secura Bio, Inc. ($1,804) |
| 2018 | $4,998 | 179 | AstraZeneca Pharmaceuticals LP ($2,362) |
| 2017 | $2,828 | 149 | E.R. Squibb & Sons, L.L.C. ($590.97) |
All Payment Transactions
931 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Rare Disease | ||||||
| 12/17/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Bone Health | ||||||
| 12/06/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Hematology | ||||||
| 12/03/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $19.59 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $38.10 | General |
| Category: Oncology | ||||||
| 11/22/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $27.65 | General |
| Category: Hematology | ||||||
| 11/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.56 | General |
| 11/07/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: BioOncology | ||||||
| 11/05/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Oncology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.82 | General |
| 10/22/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/18/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.58 | General |
| Category: Hematology/Oncology | ||||||
| 10/17/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: DESMOID TUMORS | ||||||
| 10/15/2024 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Food and Beverage | In-kind items and services | $37.17 | General |
| Category: Oncology | ||||||
| 10/15/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Hematology | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 54 | 3,901 | 33,493 | $1.4M | $439,111 |
| 2022 | 53 | 3,797 | 38,579 | $1.6M | $508,278 |
| 2021 | 67 | 4,915 | 106,236 | $2.2M | $680,047 |
| 2020 | 77 | 6,499 | 214,381 | $5.2M | $1.7M |
All Medicare Procedures & Services
251 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 17 | 4,011 | $376,741 | $143,501 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 265 | 646 | $123,715 | $58,447 | 47.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 32 | 2,521 | $93,492 | $43,856 | 46.9% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 18 | 1,800 | $75,816 | $29,956 | 39.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 43 | 183 | $63,320 | $17,238 | 27.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 90 | 765 | $114,750 | $16,273 | 14.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 333 | 1,082 | $32,687 | $11,170 | 34.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 85 | 236 | $31,607 | $10,974 | 34.7% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 51 | 64 | $41,600 | $10,576 | 25.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 347 | 1,162 | $32,292 | $8,791 | 27.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 190 | 521 | $25,373 | $6,961 | 27.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 322 | 893 | $6,965 | $6,800 | 97.6% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 103 | 744 | $24,723 | $6,780 | 27.4% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 37 | 389 | $24,118 | $5,867 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 96 | $12,488 | $5,473 | 43.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 126 | 519 | $26,469 | $5,288 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 42 | $10,794 | $5,059 | 46.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $11,215 | $4,736 | 42.2% |
| 83550 | Iron binding capacity | Office | 2023 | 163 | 435 | $13,594 | $3,728 | 27.4% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 205 | 615 | $13,272 | $3,641 | 27.4% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2023 | 93 | 177 | $12,002 | $3,270 | 27.2% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2023 | 66 | 141 | $10,489 | $2,855 | 27.2% |
| 83540 | Iron level | Office | 2023 | 160 | 426 | $9,858 | $2,701 | 27.4% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 51 | 63 | $40,950 | $2,657 | 6.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 57 | $4,275 | $2,655 | 62.1% |
About Dr. William Mitchell, MD
Dr. William Mitchell, MD is a Internal Medicine healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811949308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Mitchell, MD has received a total of $31,201 in payments from pharmaceutical and medical device companies, with $1,574 received in 2024. These payments were reported across 931 transactions from 94 companies. The most common payment nature is "Food and Beverage" ($17,806).
As a Medicare-enrolled provider, Mitchell has provided services to 19,112 Medicare beneficiaries, totaling 392,689 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 251 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Huntersville, NC
- Active Since 05/16/2006
- Last Updated 08/27/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811949308
Products in Payments
- FARYDAK (Drug) $4,135
- TAGRISSO (Drug) $2,412
- KISQALI (Drug) $1,607
- JEVTANA (Drug) $1,439
- TAZVERIK (Drug) $1,366
- ADAKVEO (Biological) $1,360
- Yescarta (Drug) $1,130
- OPDIVO (Biological) $807.38
- BRUKINSA (Drug) $741.09
- JAKAFI (Drug) $537.50
- TECENTRIQ (Biological) $419.91
- MEKINIST (Drug) $400.35
- Cabometyx (Drug) $354.96
- EMPLICITI (Biological) $330.13
- LYNPARZA (Drug) $317.29
- XPOVIO (Drug) $313.96
- Lenvima (Drug) $284.77
- XTANDI (Drug) $265.07
- AFINITOR (Drug) $257.89
- NINLARO (Drug) $257.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntersville
Alexis Smith, D.o, D.O
Internal Medicine — Payments: $492,236
Glen Kowalchuk, Md, MD
Internal Medicine — Payments: $93,721
William Hoover, Md, MD
Internal Medicine — Payments: $33,144
Poras Patel
Internal Medicine — Payments: $20,257
Jennifer Dallas, Md, MD
Internal Medicine — Payments: $17,309
Dr. Stacy Le, M.d, M.D
Internal Medicine — Payments: $13,752